Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 615,047
  • Shares Outstanding, K 216,566
  • Annual Sales, $ 0 K
  • Annual Income, $ -58,370 K
  • 60-Month Beta 4.24
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.39
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 136.11% ( -39.93%)
  • Historical Volatility 90.69%
  • IV Percentile 47%
  • IV Rank 18.33%
  • IV High 300.77% on 06/06/22
  • IV Low 99.15% on 05/04/22
  • Put/Call Vol Ratio 0.13
  • Today's Volume 4,540
  • Volume Avg (30-Day) 4,845
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 97,733
  • Open Int (30-Day) 95,364

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.33 +21.89%
on 07/26/22
2.99 -5.02%
on 07/13/22
+0.09 (+3.27%)
since 07/12/22
3-Month
1.86 +52.69%
on 06/15/22
3.11 -8.68%
on 07/08/22
+0.93 (+48.69%)
since 05/12/22
52-Week
1.67 +70.06%
on 05/12/22
17.65 -83.91%
on 11/03/21
-5.13 (-64.37%)
since 08/12/21

Most Recent Stories

More News
Here's How This Beaten-Down Stock Could 10X by 2024

A moonshot won't be necessary, but it'll require a bit of a pivot.

PFE : 50.11 (+3.77%)
OCGN : 2.84 (+5.97%)
1 Robinhood Stock to Avoid Right Now

Popularity is not always a good measure of business performance.

OCGN : 2.84 (+5.97%)
Ocugen, Inc. (OCGN) Q2 2022 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2022.

OCGN : 2.84 (+5.97%)
Ocugen Provides Business Update & Second Quarter 2022 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET...

OCGN : 2.84 (+5.97%)
Ocugen Q2 Preview: Rebound Quarter Inbound?

Ocugen shares have struggled over the last year, declining more than 60% in value and vastly underperforming the S&P 500.

OCGN : 2.84 (+5.97%)
Ocugen To Host Conference Call on Friday, August 5 at 8:30 a.m. ET to Discuss Business Updates and Second Quarter 2022 Financial Results

MALVERN, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,...

OCGN : 2.84 (+5.97%)
Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today

Healthcare has become a bona fide stock picker's market this year.

JPM : 122.13 (+1.66%)
OCGN : 2.84 (+5.97%)
SRNE : 2.63 (+6.05%)
VBIV : 1.2200 (+10.91%)
Why Ocugen Is Climbing Today

India will soon be giving away doses of Covaxin for free.

OCGN : 2.84 (+5.97%)
Why Ocugen Stock Is Sinking Today

What goes up can come down.

OCGN : 2.84 (+5.97%)
Why Ocugen Stock Ascended Today

Its collaborator in India got a thumbs-up from regulators.

OCGN : 2.84 (+5.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 3.09
2nd Resistance Point 2.98
1st Resistance Point 2.91
Last Price 2.84
1st Support Level 2.73
2nd Support Level 2.63
3rd Support Level 2.56

See More

52-Week High 17.65
Fibonacci 61.8% 11.55
Fibonacci 50% 9.66
Fibonacci 38.2% 7.77
Last Price 2.84
52-Week Low 1.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar